Germany· DE-A57-da3cdd885e250eee
Perfan
A enoximone product containing enoximone, registered in Germany by Carinopharm Gmbh. The same ATC class is registered in 4 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Enoximone is registered in 4 of 19 countries.
Countries holding a registration under ATC C01CE03 (enoximone), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 1 of them publish a price we can compare per daily dose
Enoximone · ATC C01CE03
4 / 19 countries
- Franceprice
- Germany
- Netherlands
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Enoximone
- Manufacturer
- Carinopharm Gmbh
- Country
- Germany (DE)
- ATC code
- C01CE03
- ATC class
- Enoximone
- Defined daily dose
- 1 g, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Enoximone in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsPerfan, concentraat voor oplossing voor infusie 5 mg/mlCarinopharm GmbH
- FrancePERFANE 100 mg/20 ml, solution injectable à diluer pour voie I.V.CARINOPHARM (ALLEMAGNE)
- United KingdomPerfan 100mg/20ml solution for injection ampoulesMacure Pharma UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- France · Perfane
- United Kingdom (Northern Ireland) · Perfan
- Italy · Perfan
- Netherlands · Perfan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/43a8dc2f-fb63-4e5c-9305-cdd7d710e046 GET /v1/drugs/43a8dc2f-fb63-4e5c-9305-cdd7d710e046?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Enoximone",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about enoximone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.